16 February 2023

Diabetes Endocrinology longread Obesity Pharmaceuticals Political

Who deserves Ozempic, anyway?

16 February 2023

Diabetes Obesity Pharmaceuticals

Ozempic arrives back in Australia

13 February 2023

Clinical Obesity

Coming up: Metabolic syndrome in children

13 February 2023

Chronic Disease Mental Health Obesity

Suicide and liver risk after bariatric surgery

23 January 2023

Obesity Rheumatology

Time to address obesity in rheumatic patients

23 January 2023

Nutrition Obesity

Obesity blunts benefits of vitamin D supplements

8 December 2022

Obesity Rheumatology

Metabolic syndrome increases gout risk

7 December 2022

Clinical Obesity

Managing obesity in women – expert panel

2 December 2022

Diabetes Obesity PBS TGA

TGA threatens heavy fines for promoting semaglutide

30 November 2022

Clinical Obesity

Managing obesity in women

23 November 2022

Clinical Obesity

Coming up: Managing obesity in women

17 November 2022

Clinical Obesity Pregnancy

Product explainer – The role of Liraglutide 3mg in weight management

4 November 2022

Obesity Paediatrics

Is child obesity really going to shorten lives?

3 November 2022

Diabetes Obesity PBS Pharmaceuticals

It’s a bad time to start patients on -glutides

31 October 2022

Obesity

Fighting the obesity battle early

13 October 2022

Alcohol Drugs Obesity Political Reform Smoking

Cancer: are we ignoring what we can change?